Literature DB >> 21475328

The role of metastasectomy in metastatic renal cell carcinoma.

Michael Staehler1.   

Abstract

Although new treatments can prolong progression-free and overall survival in patients with renal cell carcinoma (RCC), the cure rate remains low and surgical resection of the primary tumor and metastases are still the most important treatment options to eliminate RCC or achieve long-term progression-free survival.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21475328     DOI： 10.1038/nrurol.2011.30

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  9 in total

1.  Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy.

Authors:  M Johannsen; M Staehler; C-H Ohlmann; A Flörcken; A Schmittel; T Otto; A Bex; P Hein; K Miller; S Weikert; V Grünwald
Journal:  Ann Oncol       Date:  2010-09-24       Impact factor: 32.976

2.  Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis.

Authors:  Michael D Staehler; Jessica Kruse; Nicolas Haseke; Thomas Stadler; Alexander Roosen; Alexander Karl; Christian G Stief; Karl W Jauch; Christiane J Bruns
Journal:  World J Urol       Date:  2010-05-04       Impact factor: 4.226

3.  Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.

Authors:  Jose A Karam; Brian I Rini; Leticia Varella; Jorge A Garcia; Robert Dreicer; Toni K Choueiri; Eric Jonasch; Surena F Matin; Steven C Campbell; Christopher G Wood; Nizar M Tannir
Journal:  J Urol       Date:  2010-12-17       Impact factor: 7.450

4.  Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma.

Authors:  Hauke Winter; Georgios Meimarakis; Martin K Angele; Manuela Hummel; Michael Staehler; Ralf-Thorsten Hoffmann; Rudolf A Hatz; Florian Löhe
Journal:  J Urol       Date:  2010-09-17       Impact factor: 7.450

5.  Survival after complete surgical resection of multiple metastases from renal cell carcinoma.

Authors:  Angela L Alt; Stephen A Boorjian; Christine M Lohse; Brian A Costello; Bradley C Leibovich; Michael L Blute
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

6.  Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.

Authors:  Robert J Motzer; Jennifer Bacik; Lawrence H Schwartz; Victor Reuter; Paul Russo; Stephanie Marion; Madhu Mazumdar
Journal:  J Clin Oncol       Date:  2004-02-01       Impact factor: 44.544

7.  Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Authors:  Daniel Y C Heng; Wanling Xie; Meredith M Regan; Mark A Warren; Ali Reza Golshayan; Chakshu Sahi; Bernhard J Eigl; J Dean Ruether; Tina Cheng; Scott North; Peter Venner; Jennifer J Knox; Kim N Chi; Christian Kollmannsberger; David F McDermott; William K Oh; Michael B Atkins; Ronald M Bukowski; Brian I Rini; Toni K Choueiri
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

8.  Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy.

Authors:  John M L Ebos; Christina R Lee; James G Christensen; Anthony J Mutsaers; Robert S Kerbel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

9.  Bone metastases from renal cell carcinoma: patient survival after surgical treatment.

Authors:  Andreas Fottner; Melinda Szalantzy; Lilly Wirthmann; Michael Stähler; Andrea Baur-Melnyk; Volkmar Jansson; Hans Roland Dürr
Journal:  BMC Musculoskelet Disord       Date:  2010-07-03       Impact factor: 2.362
  9 in total
  8 in total

Review 1.  Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Authors:  Dae Y Kim; Jose A Karam; Christopher G Wood
Journal:  World J Urol       Date:  2014-04-18       Impact factor: 4.226

2.  Time-dependent change in relapse sites of renal cell carcinoma after curative surgery.

Authors:  Go Noguchi; Noboru Nakaigawa; Masataka Taguri; Sohgo Tsutsumi; Yoko Saito; Sachi Fukui; Masato Yasui; Takashi Tokita; Taku Mitome; Tomoyuki Tatenuma; Shinnosuke Kuroda; Koichi Abe; Daiki Ueno; Kazuhiro Namura; Susumu Umemoto; Akitoshi Takizawa; Junichi Ohta; Teiichiro Ueki; Takeshi Watanabe; Kazuki Kobayashi; Keiichi Kondo; Takeshi Kishida; Hitomi Kanno; Kazuo Kitami; Takeharu Yamanaka; Masahiro Yao
Journal:  Clin Exp Metastasis       Date:  2018-03-07       Impact factor: 5.150

Review 3.  Surgical intervention for pulmonary metastases.

Authors:  Joachim Pfannschmidt; Gerlinde Egerer; Marc Bischof; Michael Thomas; Hendrik Dienemann
Journal:  Dtsch Arztebl Int       Date:  2012-10-05       Impact factor: 5.594

4.  Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis.

Authors:  Steffen Rausch; Johanna Beermann; Marcus Scharpf; Jörg Hennenlotter; Falko Fend; Arnulf Stenzl; Daniel Schollenberger; Jens Bedke; Stephan Kruck
Journal:  World J Urol       Date:  2016-03-19       Impact factor: 4.226

5.  Oncological outcomes after cytoreductive nephrectomy for patients with metastatic renal cell carcinoma with inferior vena caval tumor thrombus.

Authors:  Hideaki Miyake; Takayuki Sugiyama; Ryota Aki; Yuto Matsushita; Keita Tamura; Daisuke Motoyama; Toshiki Ito; Atsushi Otsuka
Journal:  Int J Clin Oncol       Date:  2018-01-13       Impact factor: 3.402

6.  Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic model.

Authors:  Aline F Fares; Daniel V Araujo; Vinicius Calsavara; Augusto Obuti Saito; Maria Nirvana Formiga; Aldo A Dettino; Stenio Zequi; Walter H da Costa; Isabela W Cunha
Journal:  Ecancermedicalscience       Date:  2019-10-14

7.  Metastatic Immune-Related Genes for Affecting Prognosis and Immune Response in Renal Clear Cell Carcinoma.

Authors:  Si Sun; Weipu Mao; Lilin Wan; Kehao Pan; Liting Deng; Lei Zhang; Guangyuan Zhang; Ming Chen
Journal:  Front Mol Biosci       Date:  2022-01-28

8.  Pulmonary and chest wall metastasectomy in urogenital tumors: a single center experience and review of literature.

Authors:  Seyd Hossein Fattahi Masoum; Behzad Feizzdeh Kerigh; Alireza Goreifi
Journal:  Nephrourol Mon       Date:  2014-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.